The Journal of Allergy and Clinical Immunology
Volume 124, Issue 4 , Pages 681-687.e3 , October 2009

Phenotypic determinants of uncontrolled asthma

  • Valérie Siroux, PhD

      Affiliations

    • INSERM, Institut National de la Santé et de la Recherche Médicale, U823, Institut Albert Bonniot, Grenoble, France
    • Université Joseph Fourier, Grenoble, France
    • Corresponding Author InformationReprint requests: Valérie Siroux, Centre de Recherche INSERM/UJF U823, Institut Albert Bonniot, BP 170, 38042 Grenoble Cedex 9, France.
    • ,
  • Anne Boudier, MSc

      Affiliations

    • INSERM, Institut National de la Santé et de la Recherche Médicale, U823, Institut Albert Bonniot, Grenoble, France
    • Université Joseph Fourier, Grenoble, France
    • ,
  • Jean Bousquet, MD

      Affiliations

    • CHU Centre Hospitalier Universitaire, Montpellier, France
    • INSERM, Institut National de la Santé et de la Recherche Médicale, U780, Villejuif, France
    • ,
  • Jean-Louis Bresson, MD

      Affiliations

    • CIC, Centre d'Investigation Clinique, Necker, Paris, France
    • ,
  • Jean-Luc Cracowski, MD

      Affiliations

    • INSERM, Institut National de la Santé et de la Recherche Médicale CIC3, Grenoble, France
    • ,
  • Joane Ferran, BSc

      Affiliations

    • Clinique de Pneumology, CHU, Grenoble, France
    • ,
  • Frédéric Gormand, MD

      Affiliations

    • CHU, Lyon, France
    • ,
  • Jocelyne Just, MD

      Affiliations

    • Hopital Trousseau, Paris, France
    • ,
  • Nicole Le Moual, PhD

      Affiliations

    • INSERM, Institut National de la Santé et de la Recherche Médicale, U780, Villejuif, France
    • Univ Paris-Sud, IFR69, Villejuif, France
    • ,
  • Sophie Morange, MD

      Affiliations

    • CIC, Marseille, France
    • ,
  • Rachel Nadif, PhD

      Affiliations

    • INSERM, Institut National de la Santé et de la Recherche Médicale, U780, Villejuif, France
    • Univ Paris-Sud, IFR69, Villejuif, France
    • ,
  • Marie-Pierre Oryszczyn, BSc

      Affiliations

    • INSERM, Institut National de la Santé et de la Recherche Médicale, U780, Villejuif, France
    • Univ Paris-Sud, IFR69, Villejuif, France
    • ,
  • Christophe Pison, MD

      Affiliations

    • INSERM, Institut National de la Santé et de la Recherche Médicale, U780, Villejuif, France
    • Clinique de Pneumology, CHU, Grenoble, France
    • Institut National de la Santé et de la Recherche Médicale U884, Grenoble, France
    • ,
  • Pierre Scheinmann, MD

      Affiliations

    • Hopital Necker, Paris, France
    • Université Paris Descartes, Paris, France
    • ,
  • Raphaëlle Varraso, PhD

      Affiliations

    • INSERM, Institut National de la Santé et de la Recherche Médicale, U780, Villejuif, France
    • Univ Paris-Sud, IFR69, Villejuif, France
    • ,
  • Daniel Vervloet, MD

      Affiliations

    • CIC, Marseille, France
    • ,
  • Isabelle Pin, MD

      Affiliations

    • INSERM, Institut National de la Santé et de la Recherche Médicale, U823, Institut Albert Bonniot, Grenoble, France
    • Université Joseph Fourier, Grenoble, France
    • Pédiatrie, CHU, Grenoble, France
    • ,
  • Francine Kauffmann, MD

      Affiliations

    • INSERM, Institut National de la Santé et de la Recherche Médicale, U780, Villejuif, France
    • Univ Paris-Sud, IFR69, Villejuif, France
    • ,
  • Epidemiological Study on the Genetics and Environment of Asthma

Received 5 January 2009 ,Revised 11 May 2009 ,Accepted 1 June 2009.

References 

  1. Global Initiative for Asthma. Global strategy for asthma management and prevention. Bethesda (MD): National Heart, Lung, and Blood Institute, National Institutes of Health; 1995 (updated 2006). NIH publication no. 95-3659. Available at: http://www.ginasthma.org. Accessed December 15, 2009.
  2. National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. July 1997 (Updated August 2007). NIH publication no. 07-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed December 15, 2009.
  3. Van Ganse E, Laforest L, Pietri G, Boissel JP, Gormand F, Ben-Joseph R, et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J. 2002;20:260–267
  4. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40–47
  5. de Marco R, Bugiani M, Cazzoletti L, Carosso A, Accordini S, Buriani O, et al. The control of asthma in Italy: a multicentre descriptive study on young adults with doctor diagnosed current asthma. Allergy. 2003;58:221–228
  6. Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007;120:1360–1367
  7. Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med. 2002;96:142–149
  8. Ponte EV, Franco R, Nascimento HF, Souza-Machado A, Cunha S, Barreto ML, et al. Lack of control of severe asthma is associated with co-existence of moderate-to-severe rhinitis. Allergy. 2008;63:564–569
  9. Chaudhuri R, McSharry C, McCoard A, Livingston E, Hothersall E, Spears M, et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy. 2008;63:132–135
  10. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur Respir J. 2000;15:470–477
  11. Lavoie KL, Bacon SL, Labrecque M, Cartier A, Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med. 2006;100:648–657
  12. Mosen DM, Schatz M, Magid DJ, Camargo CA. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol. 2008;122:507–511
  13. Schatz M, Mosen DM, Kosinski M, Vollmer WM, Magid DJ, O'Connor E, et al. Predictors of asthma control in a random sample of asthmatic patients. J Asthma. 2007;44:341–345
  14. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170:836–844
  15. Kauffmann F, Dizier MH, Pin I, Paty E, Gormand F, Vervloet D, et al. Epidemiological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy: phenotype issues. Am J Respir Crit Care Med. 1997;156:S123–S129
  16. Kauffmann F, Dizier MH, Annesi-Maesano I, Bousquet J, Charpin D, Demenais F, et al. EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)—descriptive characteristics. Clin Exp Allergy. 1999;29(suppl 4):17–21
  17. Cerveri I, Locatelli F, Zoia MC, Corsico A, Accordini S, de Marco R. International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). Eur Respir J. 1999;14:288–294
  18. Frey U, Suki B. Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control. Lancet. 2008;372:1088–1099
  19. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol. 2007;119:1454–1461
  20. Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax. 2008;63:14–20
  21. Laforest L, Van Ganse E, Devouassoux G, Bousquet J, Chretin S, Bauguil G, et al. Influence of patients' characteristics and disease management on asthma control. J Allergy Clin Immunol. 2006;117:1404–1410
  22. Varraso R, Siroux V, Maccario J, Pin I, Kauffmann F. Asthma severity is associated with body mass index and early menarche in women. Am J Respir Crit Care Med. 2005;171:334–339
  23. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J. 2006;27:495–503
  24. Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med. 2007;101:2240–2247
  25. de Marco R, Marcon A, Jarvis D, Accordini S, Almar E, Bugiani M, et al. Prognostic factors of asthma severity: a 9-year international prospective cohort study. J Allergy Clin Immunol. 2006;117:1249–1256
  26. Nadif R, Siroux V, Oryszczyn MP, Ravault C, Pison C, Pin I, et al. Heterogeneity of asthma according to blood inflammatory patterns. Thorax. 2009;64:374–380
  27. Naqvi M, Choudhry S, Tsai HJ, Thyne S, Navarro D, Nazario S, et al. Association between IgE levels and asthma severity among African American, Mexican, and Puerto Rican patients with asthma. J Allergy Clin Immunol. 2007;120:137–143
  28. Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005;60:309–316
  29. Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG, Gergen P, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med. 1997;336:1356–1363
  30. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ. 2002;324:763
  31. Lewis SA, Weiss ST, Platts-Mills TA, Burge H, Gold DR. The role of indoor allergen sensitization and exposure in causing morbidity in women with asthma. Am J Respir Crit Care Med. 2002;165:961–966
  32. Wisnivesky JP, Sampson H, Berns S, Kattan M, Halm EA. Lack of association between indoor allergen sensitization and asthma morbidity in inner-city adults. J Allergy Clin Immunol. 2007;120:113–120
  33. The ENFUMOSA study group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J. 2003;22:470–477
  34. Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ. 2002;325:411–414
  35. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J. 2006;27:615–626
  36. Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax. 2005;60:282–287
  37. Bousquet J, Gaugris S, Kocevar VS, Zhang Q, Yin DD, Polos PG, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clin Exp Allergy. 2005;35:723–727

 Supported by grants from Merck Sharp & Dohme (MSD); Hospital program of clinical research (PHRC)-Paris; National Research Agency - Health environment, health-work program; National Research Agency (ANR)- Biological collections for health program; French Agency of health safety, environment and work (AFSSET) and the Isere committee against respiratory diseases (COMARES).

 Disclosure of potential conflict of interest: C. Pison has served as a consultant for GlaxoSmithKline, Boehringer Ingelheim France, AstraZeneca, Nutricia, Numico, and Actéllion and has received research support from AB Science. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)00879-3

doi: 10.1016/j.jaci.2009.06.010

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 4 , Pages 681-687.e3 , October 2009

Article Tools

* Image Usage & Resolution